Financials
| Preliminary Results for Year Ended 30 June 2025 | Oct. 23, 2025 |
| Sareum Half-Year Report | Mar. 25, 2025 |
| Final Results for the Year Ended 30 June 2024 | Oct. 29, 2024 |
| Sareum Half-Year Report | Mar. 28, 2024 |
| Half-Year Report | Mar. 22, 2023 |
| Final Results for the Year Ended 30 June 2022 | Oct. 24, 2022 |
| Half-year Report | Feb. 21, 2022 |
Proxies
| Results of AGM | Dec. 19, 2024 |
| Notice of AGM, Annual Report and Accounts | Nov. 27, 2024 |
| Results of AGM | Dec. 14, 2023 |
| Notice of AGM, Annual Report and Accounts | Nov. 21, 2023 |
| Results of AGM | Dec. 16, 2022 |
| AGM Statement | Dec. 16, 2022 |
| Notice of AGM, Annual Report and Accounts | Nov. 24, 2022 |
Ownership Update
| Director’s Dealing | Mar. 27, 2025 |
| Completion of Equity Fundraise | Apr. 04, 2024 |
| Director Dealings | Nov. 08, 2023 |
| Exercise of Share Options and Director Dealings | Nov. 02, 2023 |
| Director's Dealing | Sep. 06, 2023 |
| Director Dealing | Sep. 05, 2023 |
| Director/PDMR Shareholding | Nov. 23, 2021 |
Announcements
| Update on toxicology study for SDC-1801 | Oct. 10, 2025 |
| Notice of Results and Investor Presentation | Oct. 07, 2025 |
| Exercise of Warrants | Sep. 26, 2025 |
| Exercise of Warrants | Sep. 18, 2025 |
| Exercise of Warrants | Aug. 26, 2025 |
| Exercise of Warrants | Aug. 20, 2025 |
| Sareum Collaboration with Receptor.AI | Aug. 12, 2025 |